1) Shock is characterized by decreased tissue perfusion and cellular metabolism due to an imbalance between oxygen supply and demand. It can be classified as low blood flow shock (cardiogenic, hypovolemic) or maldistribution of blood flow shock (septic, anaphylactic, neurogenic).
2) Management of shock involves identifying the cause, restoring circulating volume through fluid resuscitation, supporting vital organ function, and treating the underlying cause. General management strategies include ensuring a patent airway, maximizing oxygen delivery, and volume expansion with isotonic crystalloids.
3) The stages of shock include initial, compensated, progressive, and refractory. Treatment aims to support compensation and prevent progression
This document provides an overview of shock, including its classification, pathophysiology, stages, diagnostic studies, and collaborative care. Shock is defined as a syndrome characterized by decreased tissue perfusion and cellular metabolism due to an imbalance in oxygen supply and demand. The main types of shock discussed are cardiogenic, hypovolemic, neurogenic, anaphylactic, and septic shock. The stages of shock progression from initial to refractory are also outlined. Key aspects of shock management include identifying the cause, restoring perfusion through fluid resuscitation and vasoactive drugs if needed, and supporting failing organs.
Shock is defined as inadequate tissue perfusion resulting in decreased oxygen delivery and buildup of waste, and can progress from early compensated stages to intermediate stages involving organ damage and late irreversible stages involving multiple organ failure. The document outlines the pathophysiology and stages of shock including effects on body systems, clinical markers, causes, and treatment focusing on restoring tissue perfusion through fluid resuscitation and management of the underlying cause.
Hypovolemic shock results from trauma that causes blood loss, decreasing blood volume and lowering blood pressure. The body initially compensates through mechanisms like catecholamine release, but can progress to decompensated then irreversible shock if left untreated. Treatment focuses on fluid resuscitation through IV fluids to restore blood volume.
Cardiogenic shock occurs when the heart cannot adequately circulate blood, usually due to a heart attack damaging the left ventricle. It presents with pulmonary edema but normal blood pressures. Treatment centers on supportive care while the heart recovers.
Neurogenic shock is caused by spinal cord injury disrupting nerve signals, causing widespread vessel dilation and low blood pressure. It presents with warm skin and
Shock is defined as inadequate tissue perfusion and oxygen delivery. There are several types of shock based on the underlying pathophysiology, including cardiogenic, hypovolemic, neurogenic, anaphylactic, and septic shock. The signs and symptoms of shock progress as compensatory mechanisms become overwhelmed and include tachycardia, tachypnea, altered mental status, hypotension, and ultimately death. Treatment involves addressing the underlying cause, maintaining oxygen delivery through fluids and pressors, and supporting organ function.
This document provides information on shock, including its definition, types, pathophysiology, clinical features, and management. It defines shock as a state of inadequate tissue perfusion and oxygenation that can lead to organ dysfunction and death. The main types of shock discussed are hypovolemic, septic, and cardiogenic shock. For each type, the document outlines their pathophysiology, signs and symptoms, and general management approach. Overall, it serves as an overview of shock for medical students, covering the essential details of definitions, types, effects on organ systems, and clinical distinctions between compensated and decompensated states of shock.
Shock is a life-threatening condition defined by inadequate tissue perfusion and oxygen delivery. It can be caused by hypovolemia, cardiac dysfunction, or vasodilation. The main symptoms include low blood pressure, fast heart rate, fast breathing, and decreased urine output. Untreated shock can lead to organ failure and death. Treatment focuses on restoring circulating volume and oxygen delivery through fluid resuscitation, vasopressors, and treating the underlying cause. Prompt recognition and treatment are essential for recovery.
1. Shock is defined as inadequate tissue perfusion to meet metabolic demand and can be caused by hypovolemia, cardiac dysfunction, obstruction of blood flow, or inappropriate blood vessel dilation.
2. Clinical signs of shock include tachycardia, abnormal capillary refill time, weak pulses, hypotension, and altered mental status.
3. Management of shock involves optimizing oxygen delivery through fluid resuscitation, antibiotics, vasopressors, ventilation, and treating the underlying cause to increase blood pressure and tissue perfusion.
Shock is characterized by a systemic reduction in tissue perfusion resulting in decreased oxygen delivery. There are four main types of shock: hypovolemic, cardiogenic, obstructive, and distributive. The goals of resuscitation are to increase oxygen delivery and decrease demand. Treatment involves establishing IV access, fluid resuscitation, vasopressors, inotropes, antibiotics for infection, and treating the underlying cause. Endpoints of resuscitation include restoration of blood pressure, normalization of heart rate, urine output, lactate levels, and mental status.
2. Hypovolemic, Septic and Cardiogenic Shock.pptxfarihinizhar
油
Hypovolemic, septic, and cardiogenic shock are three types of shock discussed in the document. Hypovolemic shock occurs due to reduced circulating volume from external or internal bleeding or fluid losses. Septic shock results from toxins released during bacterial infections. Cardiogenic shock is caused by decreased cardiac output due to conditions like heart attacks or heart muscle damage that impair the heart's ability to pump effectively. Treatment for the different shock types involves immediate control of bleeding, fluid resuscitation, antibiotics for infection, and vasopressors or inotropes to support blood pressure and cardiac function.
This document provides an overview of shock, including its definition, pathophysiology, classification, signs and symptoms, initial management, and specific types such as hypovolemic, septic, cardiogenic, and obstructive shock. It defines shock as inadequate tissue perfusion and oxygen delivery, discusses the body's compensatory mechanisms and their failure in severe shock. It classifies shock into hypovolemic, cardiogenic, distributive, and obstructive types and provides details on managing each type, including damage control resuscitation for hemorrhagic shock and use of vasopressors for neurogenic shock. Key goals in shock management are outlined as well as factors like lactate and base deficit that can guide res
1. Shock is defined as a systemic state of low tissue perfusion that is inadequate for normal cellular respiration. It occurs when there is insufficient delivery of oxygen and glucose to cells, causing cells to switch from aerobic to anaerobic metabolism. If perfusion is not restored, cell death ensues.
2. The main types of shock are hypovolemic, cardiogenic, obstructive, distributive, and endocrine shock. Hypovolemic shock, the most common type, is caused by blood or fluid loss. Cardiogenic shock results from cardiac dysfunction that reduces cardiac output.
3. The goals of shock resuscitation are to increase oxygen delivery, decrease oxygen demand, improve cardiac
Shock in pediatric patients can be caused by several factors and requires early recognition and treatment to prevent progression. It is defined as inadequate oxygen delivery to meet metabolic demands. The main types are hypovolemic, distributive, cardiogenic, and obstructive shock. Septic shock is a major cause of mortality and morbidity in children. The goals of treatment are to increase oxygen delivery, decrease demands, and increase oxygen content through rapid fluid resuscitation and inotropic support. Early identification and treatment of the underlying cause can help avoid irreversible organ damage from shock.
SHOCK SYNDROMESHOCK SYNDROME
Shock is a condition in which the cardiovascular system
fails to perfuse tissues adequately
An impaired cardiac pump, circulatory system, and/or
volume can lead to compromised blood flow to tissues
Inadequate tissue perfusion can result in:
generalized cellular hypoxia (starvation)
widespread impairment of cellular metabolism
tissue damage organ failure
death
ATHOPHYSIOLOGYPATHOPHYSIOLOGY
Cells switch from aerobic to anaerobic metabolism
lactic acid production
Cell function ceases & swells
membrane becomes more permeable
electrolytes & fluids seep in & out of cell
Na+/K+ pump impaired
mitochondria damage
cell death
1) Shock is a condition where the cardiovascular system fails to adequately perfuse tissues due to impaired cardiac pump function, circulatory issues, or low blood volume.
2) The main types of shock are hypovolemic (low blood volume), cardiogenic (impaired heart function), and distributive (blood vessel problems).
3) Hypovolemic shock results from internal or external fluid loss leading to decreased circulating volume and tissue perfusion. Cardiogenic shock occurs due to impaired left ventricular pumping ability despite normal blood volume.
Ganesh is a 22 year old medical student who was in a car accident. He was found to be agitated and complaining of abdominal pain. At the scene, his vital signs showed elevated breathing and heart rate with low blood pressure. Upon arrival at the emergency room, his vital signs and physical exam showed signs of shock including a distended abdomen, cold hands and feet, and dark urine. His hemoglobin was low at 7, indicating blood loss and hypovolemic shock.
Heart failure is a common condition where the heart is unable to pump enough blood to meet the body's needs. It can result from structural or functional disorders of the heart. The document provides details on the definition, causes, risk factors, pathophysiology, symptoms, diagnostic evaluation, classification systems, and treatment of heart failure. It emphasizes the importance of controlling risk factors, using medications such as ACE inhibitors and diuretics to manage symptoms, and making lifestyle changes like following a low-sodium diet and exercising regularly.
Critical Care Nurse Student | Assistant Clinical Researcher | Chairperson National Nurses of Kenya-Siaya Branch | Mentor | SRHR & Boys Advocate.
Young and energetic healthcare professional with a strong belief in the basic tenets of human development and quality of life. My key qualities include integrity, hardworking, team player and keenness to achieve results.
1. Shock is defined as inadequate tissue perfusion to meet metabolic demand and can be caused by hypovolemia, cardiac dysfunction, obstruction of blood flow, or inappropriate blood vessel dilation.
2. Clinical signs of shock include tachycardia, abnormal capillary refill time, weak pulses, hypotension, and altered mental status.
3. Management of shock involves optimizing oxygen delivery through fluid resuscitation, antibiotics, vasopressors, ventilation, and treating the underlying cause to increase blood pressure and tissue perfusion.
Shock is characterized by a systemic reduction in tissue perfusion resulting in decreased oxygen delivery. There are four main types of shock: hypovolemic, cardiogenic, obstructive, and distributive. The goals of resuscitation are to increase oxygen delivery and decrease demand. Treatment involves establishing IV access, fluid resuscitation, vasopressors, inotropes, antibiotics for infection, and treating the underlying cause. Endpoints of resuscitation include restoration of blood pressure, normalization of heart rate, urine output, lactate levels, and mental status.
2. Hypovolemic, Septic and Cardiogenic Shock.pptxfarihinizhar
油
Hypovolemic, septic, and cardiogenic shock are three types of shock discussed in the document. Hypovolemic shock occurs due to reduced circulating volume from external or internal bleeding or fluid losses. Septic shock results from toxins released during bacterial infections. Cardiogenic shock is caused by decreased cardiac output due to conditions like heart attacks or heart muscle damage that impair the heart's ability to pump effectively. Treatment for the different shock types involves immediate control of bleeding, fluid resuscitation, antibiotics for infection, and vasopressors or inotropes to support blood pressure and cardiac function.
This document provides an overview of shock, including its definition, pathophysiology, classification, signs and symptoms, initial management, and specific types such as hypovolemic, septic, cardiogenic, and obstructive shock. It defines shock as inadequate tissue perfusion and oxygen delivery, discusses the body's compensatory mechanisms and their failure in severe shock. It classifies shock into hypovolemic, cardiogenic, distributive, and obstructive types and provides details on managing each type, including damage control resuscitation for hemorrhagic shock and use of vasopressors for neurogenic shock. Key goals in shock management are outlined as well as factors like lactate and base deficit that can guide res
1. Shock is defined as a systemic state of low tissue perfusion that is inadequate for normal cellular respiration. It occurs when there is insufficient delivery of oxygen and glucose to cells, causing cells to switch from aerobic to anaerobic metabolism. If perfusion is not restored, cell death ensues.
2. The main types of shock are hypovolemic, cardiogenic, obstructive, distributive, and endocrine shock. Hypovolemic shock, the most common type, is caused by blood or fluid loss. Cardiogenic shock results from cardiac dysfunction that reduces cardiac output.
3. The goals of shock resuscitation are to increase oxygen delivery, decrease oxygen demand, improve cardiac
Shock in pediatric patients can be caused by several factors and requires early recognition and treatment to prevent progression. It is defined as inadequate oxygen delivery to meet metabolic demands. The main types are hypovolemic, distributive, cardiogenic, and obstructive shock. Septic shock is a major cause of mortality and morbidity in children. The goals of treatment are to increase oxygen delivery, decrease demands, and increase oxygen content through rapid fluid resuscitation and inotropic support. Early identification and treatment of the underlying cause can help avoid irreversible organ damage from shock.
SHOCK SYNDROMESHOCK SYNDROME
Shock is a condition in which the cardiovascular system
fails to perfuse tissues adequately
An impaired cardiac pump, circulatory system, and/or
volume can lead to compromised blood flow to tissues
Inadequate tissue perfusion can result in:
generalized cellular hypoxia (starvation)
widespread impairment of cellular metabolism
tissue damage organ failure
death
ATHOPHYSIOLOGYPATHOPHYSIOLOGY
Cells switch from aerobic to anaerobic metabolism
lactic acid production
Cell function ceases & swells
membrane becomes more permeable
electrolytes & fluids seep in & out of cell
Na+/K+ pump impaired
mitochondria damage
cell death
1) Shock is a condition where the cardiovascular system fails to adequately perfuse tissues due to impaired cardiac pump function, circulatory issues, or low blood volume.
2) The main types of shock are hypovolemic (low blood volume), cardiogenic (impaired heart function), and distributive (blood vessel problems).
3) Hypovolemic shock results from internal or external fluid loss leading to decreased circulating volume and tissue perfusion. Cardiogenic shock occurs due to impaired left ventricular pumping ability despite normal blood volume.
Ganesh is a 22 year old medical student who was in a car accident. He was found to be agitated and complaining of abdominal pain. At the scene, his vital signs showed elevated breathing and heart rate with low blood pressure. Upon arrival at the emergency room, his vital signs and physical exam showed signs of shock including a distended abdomen, cold hands and feet, and dark urine. His hemoglobin was low at 7, indicating blood loss and hypovolemic shock.
Heart failure is a common condition where the heart is unable to pump enough blood to meet the body's needs. It can result from structural or functional disorders of the heart. The document provides details on the definition, causes, risk factors, pathophysiology, symptoms, diagnostic evaluation, classification systems, and treatment of heart failure. It emphasizes the importance of controlling risk factors, using medications such as ACE inhibitors and diuretics to manage symptoms, and making lifestyle changes like following a low-sodium diet and exercising regularly.
Critical Care Nurse Student | Assistant Clinical Researcher | Chairperson National Nurses of Kenya-Siaya Branch | Mentor | SRHR & Boys Advocate.
Young and energetic healthcare professional with a strong belief in the basic tenets of human development and quality of life. My key qualities include integrity, hardworking, team player and keenness to achieve results.
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...KHUSHAL CHAVAN
油
This presentation provides an in-depth understanding of solubilization and its critical role in pharmaceutical formulations. It covers:
Definition & Mechanisms of Solubilization
Role of surfactants, micelles, and bile salts in drug solubility
Factors affecting solubilization (pH, polarity, particle size, temperature, etc.)
Methods to enhance drug solubility (Buffers, Co-solvents, Surfactants, Complexation, Solid Dispersions)
Advanced approaches (Polymorphism, Salt Formation, Co-crystallization, Prodrugs)
This resource is valuable for pharmaceutical scientists, formulation experts, regulatory professionals, and students interested in improving drug solubility and bioavailability.
Here discussing various cases of Obstructive jaundice namely Choledocholithiassis, Biliary atresia, Carcinoma Pancreas, Periampullary Carcinoma and Cholangiocarcinoma.
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxdrnidhimnd
油
The shoulder complex acts as in coordinated fashion to provide the smoothest and greatest range of motion possible of the upper limb.
Combined motion of GH and ST joint of shoulder complex helps in:
Distribution of motion between other two joints.
Maintenance of glenoid fossa in optimal position.
Maintenance of good length tension
Although some amount of glenohumeral motion may occur while the other shoulder articulations remain stabilized, movement of the humerus more commonly involves some movement at all three shoulder joints.
Presentaci坦 que va acompanyar la demostraci坦 prctica de metge d'Innovaci坦 Jos辿 Ferrer sobre el projecte Benestar de BSA, nom d'IDIAP Pere Gol, el 5 de mar巽 de 2025 a l'estand de XarSMART al Mobible Word Congress.
Unit 1: Introduction to Histological and Cytological techniques
Differentiate histology and cytology
Overview on tissue types
Function and components of the compound light microscope
Overview on common Histological Techniques:
o Fixation
o Grossing
o Tissue processing
o Microtomy
o Staining
o Mounting
Application of histology and cytology
Dr. Vincenzo Giordano began his medical career 2011 at Aberdeen Royal Infirmary in the Department of Cardiothoracic Surgery. Here, he performed complex adult cardiothoracic surgical procedures, significantly enhancing his proficiency in patient critical care, as evidenced by his FCCS certification.
Chair and Presenters Sara A. Hurvitz, MD, FACP, Carey K. Anders, MD, FASCO, and Vyshak Venur, MD, discuss metastatic HER2-positive breast cancer in this CME/NCPD/CPE/AAPA/IPCE activity titled Fine-Tuning the Selection and Sequencing of HER2-Targeting Therapies in HER2-Positive MBC With and Without CNS Metastases: Expert Guidance on How to Individualize Therapy Based on Latest Evidence, Disease Features, Treatment Characteristics, and Patient Needs and Preferences. For the full presentation, downloadable Practice Aids, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4f8sUs7. CME/NCPD/CPE/AAPA/IPCE credit will be available until March 2, 2026.
This presentation provides a detailed exploration of the morphological and microscopic features of pneumonia, covering its histopathology, classification, and clinical significance. Designed for medical students, pathologists, and healthcare professionals, this lecture differentiates bacterial vs. viral pneumonia, explains lobar, bronchopneumonia, and interstitial pneumonia, and discusses diagnostic imaging patterns.
Key Topics Covered:
Normal lung histology vs. pneumonia-affected lung
Morphological changes in lobar, bronchopneumonia, and interstitial pneumonia
Microscopic features: Fibroblastic plugs, alveolar septal thickening, inflammatory cell infiltration
Stages of lobar pneumonia: Congestion, Red hepatization, Gray hepatization, Resolution
Common causative pathogens (Streptococcus pneumoniae, Klebsiella pneumoniae, Mycoplasma, etc.)
Clinical case study with diagnostic approach and differentials
Who Should Watch?
This is an essential resource for medical students, pathology trainees, and respiratory health professionals looking to enhance their understanding of pneumonias morphological aspects.
Non-Invasive ICP Monitoring for NeurosurgeonsDhaval Shukla
油
This presentation delves into the latest advancements in non-invasive intracranial pressure (ICP) monitoring techniques, specifically tailored for neurosurgeons. It covers the importance of ICP monitoring in clinical practice, explores various non-invasive methods, and discusses their accuracy, reliability, and clinical applications. Attendees will gain insights into the benefits of non-invasive approaches over traditional invasive methods, including reduced risk of complications and improved patient outcomes. This comprehensive overview is designed to enhance the knowledge and skills of neurosurgeons in managing patients with neurological conditions.
Invasive systems are commonly used for monitoring intracranial pressure (ICP) in traumatic brain injury (TBI) and are considered the gold standard. The availability of invasive ICP monitoring is heterogeneous, and in low- and middle-income settings, these systems are not routinely employed due to high cost or limited accessibility. The aim of this presentation is to develop recommendations to guide monitoring and ICP-driven therapies in TBI using non-invasive ICP (nICP) systems.
9. Low Blood Flow
Hypovolemic Shock
Absolute hypovolemia: Loss of intravascular
fluid volume
Hemorrhage
GI loss (e.g., vomiting, diarrhea)
Fistula drainage
Diabetes insipidus
Hyperglycemia
Diuresis
10. Low Blood Flow
Hypovolemic Shock (Contd)
Relative hypovolemia
Results when fluid volume moves out of the
vascular space into extravascular space (e.g.,
interstitial or intracavitary space)
Termed third spacing
11. Pathophysiology of Hypovolemic Shock
Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
12. Low Blood Flow
Hypovolemic Shock
Response to acute volume loss depends on
Extent of injury or insult
Age
General state of health
13. Low Blood Flow
Hypovolemic Shock (Contd)
Clinical manifestations
Anxiety
Tachypnea
Increase in CO, heart rate
Decrease in stroke volume, PAWP, UO
If loss is >30%, blood volume is replaced
14. Maldistribution of Blood Flow
Neurogenic Shock
Hemodynamic phenomenon that can occur
within 30 minutes of a spinal cord injury at the
fifth thoracic (T5) vertebra or above and can
last up to 6 weeks
Results in massive vasodilation leading to
pooling of blood in vessels
15. Pathophysiology of Neurogenic Shock
Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
16. Maldistribution of Blood Flow
Neurogenic Shock (Contd)
Clinical manifestations
Hypotension
Bradycardia
Temperature dysregulation (resulting in heat loss)
Dry skin
Poikilothermia (taking on the temperature of the
environment)
17. Maldistribution of Blood Flow
Anaphylactic Shock
Acute, life-threatening hypersensitivity
reaction
Massive vasodilation
Release of mediators
Capillary permeability
18. Maldistribution of Blood Flow
Anaphylactic Shock (Contd)
Clinical manifestations
Anxiety, confusion, dizziness
Tachycardia, tachypnea, hypotension
Wheezing, stridor
Sense of impending doom
Chest pain
19. Maldistribution of Blood Flow
Anaphylactic Shock (Contd)
Clinical manifestations
Swelling of the lips and tongue, angioedema
Wheezing, stridor
Flushing, pruritus, urticaria
Respiratory distress and circulatory failure
20. Maldistribution of Blood Flow
Septic Shock
Sepsis: Systemic inflammatory response to
documented or suspected infection
Severe sepsis = Sepsis + Organ dysfunction
21. Maldistribution of Blood Flow
Septic Shock (Contd)
Septic shock = Presence of sepsis with
hypotension despite fluid resuscitation +
Presence of tissue perfusion abnormalities
22. Maldistribution of Blood Flow
Septic Shock (Contd)
Mortality rates as high as 50%
Primary causative organisms
Gram-negative and gram-positive bacteria
Endotoxin stimulates inflammatory response
23. Pathophysiology of Septic Shock
Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
24. Maldistribution of Blood Flow
Septic Shock
Clinical manifestations
Coagulation and inflammation
Fibrinolysis
Formation of microthrombi
Obstruction of microvasculature
Hyperdynamic state: Increased CO and decreased
SVR
25. Maldistribution of Blood Flow
Septic Shock (Contd)
Clinical manifestations
Tachypnea/hyperventilation
Temperature dysregulation
Urine output
Altered neurologic status
GI dysfunction
Respiratory failure is common
26. Stages of Shock
Initial Stage
Usually not clinically apparent
Metabolism changes from aerobic to
anaerobic
Lactic acid accumulates and must be removed by
blood and broken down by liver
Process requires unavailable O2
27. Stages of Shock
Compensatory Stage (Nonprogressive)
Clinically apparent
Neural
Hormonal
Biochemical compensatory mechanisms
Attempts are aimed at overcoming
consequences of anaerobic metabolism and
maintaining homeostasis
28. Stages of Shock
Compensatory Stage (Nonprogressive)
Baroreceptors in carotid and aortic bodies
activate SNS in response to BP
Vasoconstriction while blood to vital organs
maintained
Blood to kidneys activates renin
angiotensin system
Venous return to heart, CO, BP
30. Stages of Shock
Compensatory Stage (Nonprogressive Contd)
If perfusion deficit corrected, patient recovers
with no residual sequelae
If deficit not corrected, patient enters
progressive stage
31. Stages of Shock
Progressive Stage (intermediate)
Begins when compensatory mechanisms fail
Aggressive interventions to prevent multiple
organ dysfunction syndrome
32. Progressive (intermediate)Stage of Shock
Copyright 息 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
33. Stages of Shock
Progressive Stage (intermediate Contd)
Hallmarks of cellular perfusion and altered
capillary permeability:
Leakage of protein into interstitial space
Systemic interstitial edema
34. Stages of Shock
Progressive Stage (intermediate Contd)
Anasarca (severe generalized edema)
Fluid leakage affects solid organs and peripheral tissues
Blood flow to pulmonary capillaries
35. Stages of Shock
Progressive Stage (intermediate Contd)
Movement of fluid from pulmonary
vasculature to interstitium
Pulmonary edema
Bronchoconstriction
Residual capacity
36. Stages of Shock
Progressive Stage (intermediate Contd)
Fluid moves into alveoli
Edema
Decreased surfactant
Worsening V/Q mismatch
Tachypnea
Crackles
Increased work of breathing
37. Stages of Shock
Progressive Stage (intermediate Contd)
CO begins to fall
Decreased peripheral perfusion
Hypotension
Weak peripheral pulses
Ischemia of distal extremities
38. Stages of Shock
Progressive Stage (intermediate Contd)
Myocardial dysfunction results in
Dysrhythmias
Ischemia
Myocardial infarction
End result: Complete deterioration of cardiovascular
system
39. Stages of Shock
Progressive Stage (intermediate Contd)
Mucosal barrier of GI system becomes
ischemic
Ulcers
Bleeding
Risk of translocation of bacteria
Decreased ability to absorb nutrients
40. Stages of Shock
Progressive Stage (intermediate Contd)
Liver fails to metabolize drugs and wastes
Jaundice
Elevated enzymes
Loss of immune function
Risk for DIC and significant bleeding
45. Diagnostic Studies
Through history and physical examination
No single study to determine shock
Blood studies
Elevation of lactate
Base deficit
12-lead ECG
Chest x-ray
Hemodynamic monitoring
46. Collaborative Care
Successful management includes
Identification of patients at risk for shock
Integration of the patients history, physical
examination, and clinical findings to establish a
diagnosis
47. Collaborative Care (Contd)
Successful management includes
Interventions to control or eliminate the cause of
the decreased perfusion
Protection of target and distal organs from
dysfunction
Provision of multisystem supportive care
49. Collaborative Care (Contd)
Cornerstone of therapy for septic,
hypovolemic, and anaphylactic shock =
volume expansion
Isotonic crystalloids (e.g., normal saline) for initial
resuscitation of shock
50. Collaborative Care (Contd)
Volume expansion
If the patient does not respond to 2 to 3 L of
crystalloids, blood administration and central
venous monitoring may be instituted
Complications of fluid resuscitation
Hypothermia
Coagulopathy
51. Collaborative Care (Contd)
Primary goal of drug therapy = correction of
decreased tissue perfusion
Vasopressor drugs (e.g., epinephrine)
Achieve/maintain MAP >60 to 65 mm Hg
Reserved for patients unresponsive to other therapies
52. Collaborative Care (Contd)
Primary goal of drug therapy = correction of
decreased tissue perfusion
Vasodilator therapy (e.g., nitroglycerin
[cardiogenic shock], nitroprusside [noncardiogenic
shock])
Achieve/maintain MAP >60 to 65 mm Hg
53. Collaborative Care (Contd)
Nutrition is vital to decreasing morbidity from
shock
Initiate enteral nutrition within the first 24 hours
54. Collaborative Care (Contd)
Nutrition is vital to decreasing morbidity from
shock
Initiate parenteral nutrition if enteral feedings
contraindicated or fail to meet at least 80% of the
caloric requirements
Monitor protein, nitrogen balance, BUN, glucose,
electrolytes
55. Collaborative Care
Cardiogenic Shock
Restore blood flow to the myocardium by
restoring the balance between O2 supply and
demand
Thrombolytic therapy
Angioplasty with stenting
Emergency revascularization
Valve replacement
56. Collaborative Care
Cardiogenic Shock (Contd)
Hemodynamic monitoring
Drug therapy (e.g., diuretics to reduce
preload)
Circulatory assist devices (e.g., intra-aortic
balloon pump, ventricular assist device)
57. Collaborative Care
Hypovolemic Shock
Management focuses on stopping the loss of
fluid and restoring the circulating volume
Fluid replacement is calculated using a 3:1
rule (3 ml of isotonic crystalloid for every 1 ml
of estimated blood loss)
58. Collaborative Care
Septic Shock
Fluid replacement (e.g., 6 to 10 L of isotonic
crystalloids and 2 to 4 L of colloids) to restore
perfusion
Hemodynamic monitoring
Vasopressor drug therapy; vasopressin for
patients refractory to vasopressor therapy
59. Collaborative Care
Septic Shock (Contd)
Intravenous corticosteroids for patients who
require vasopressor therapy, despite fluid
resuscitation, to maintain adequate BP
60. Collaborative Care
Septic Shock (Contd)
Antibiotics after obtaining cultures
(e.g., blood, wound exudate, urine, stool,
sputum)
Drotrecogin alfa (Xigris)
Major side effect: Bleeding
61. Collaborative Care
Septic Shock (Contd)
Glucose levels <150 mg/dl
Stress ulcer prophylaxis with histamine (H2)-
receptor blockers
Deep vein thrombosis prophylaxis with low-
dose unfractionated heparin or low-
molecular-weight heparin
62. Collaborative Care
Neurogenic Shock
In spinal cord injury: Spinal stability
Treatment of the hypotension and bradycardia
with vasopressors and atropine
Fluids used cautiously as hypotension is generally
not related to fluid loss
Monitor for hypothermia
63. Collaborative Care
Anaphylactic Shock
Epinephrine, diphenhydramine
Maintaining a patent airway
Nebulized bronchodilators
Endotracheal intubation or cricothyroidotomy may be
necessary
64. Collaborative Care
Anaphylactic Shock (Contd)
Aggressive fluid replacement
Intravenous corticosteroids if significant
hypotension persists after 1 to 2 hours of
aggressive therapy
65. Nursing Assessment (Contd)
ABCs: Airway, breathing, and circulation
Focused assessment of tissue perfusion
Vital signs
Peripheral pulses
Level of consciousness
Capillary refill
Skin (e.g., temperature, color, moisture)
Urine output
66. Nursing Assessment (Contd)
Brief history
Events leading to shock
Onset and duration of symptoms
Details of care received before hospitalization
Allergies
Vaccinations
67. Nursing Diagnoses
Ineffective tissue perfusion: Renal, cerebral,
cardiopulmonary, gastrointestinal, hepatic,
and peripheral
Fear
Potential complication: Organ
ischemia/dysfunction
68. Planning
Goals for patient
Assurance of adequate tissue perfusion
Restoration of normal or baseline BP
Return/recovery of organ function
Avoidance of complications from prolonged states
of hypoperfusion
69. Nursing Implementation
Health Promotion
Identify patients at risk (e.g., elderly patients,
those with debilitating illnesses or who are
immunocompromised, surgical or accidental
trauma patients)
70. Nursing Implementation (Contd)
Health Promotion
Planning to prevent shock
(e.g., monitoring fluid balance to prevent
hypovolemic shock, maintenance of handwashing
to prevent spread of infection)
71. Nursing Implementation (Contd)
Acute Interventions
Monitor the patients ongoing physical and
emotional status to detect subtle changes in the
patients condition
Plan and implement nursing interventions and
therapy
72. Nursing Implementation (Contd)
Acute Interventions
Evaluate the patients response to therapy
Provide emotional support to the patient and
family
Collaborate with other members of the health
team when warranted
73. Nursing Implementation (Contd)
Neurologic status: Orientation and level of
consciousness
Cardiac status
Continuous ECG
VS, capillary refill
Hemodynamic parameters: central venous
pressure, PA pressures, CO, PAWP
Heart sounds: Murmurs, S3, S4
74. Nursing Implementation (Contd)
Respiratory status
Respiratory rate and rhythm
Breath sounds
Continuous pulse oximetry
Arterial blood gases
Most patients will be intubated and mechanically
ventilated
75. Nursing Implementation (Contd)
Urine output
Tympanic or pulmonary arterial temperature
Skin: Temperature, pallor, flushing, cyanosis,
diaphoresis, piloerection
Bowel sounds
76. Nursing Implementation (Contd)
Nasogastric drainage/stools for occult blood
I&O, fluid and electrolyte balance
Oral care/hygiene based on O2 requirements
Passive/active range of motion
77. Nursing Implementation (Contd)
Assess level of anxiety and fear
Medication PRN
Talk to patient
Visit from clergy
Family involvement
Comfort measures
Privacy
Call light within reach
78. Evaluation
Normal or baseline, ECG, BP, CVP, and PAWP
Normal temperature
Warm, dry skin
Urinary output >0.5 ml/kg/hr
Normal RR and SaO2 90%
Verbalization of fears, anxiety